Login / Signup

Efficacy of Majoon-e-Seer Alvi Khan in dyslipidemia: a single blind randomized standard controlled clinical trial.

Mohd Aleemuddin QuamriAdil WahabMd Anzar AlamBarkat Farooqui Ali
Published in: Drug metabolism and personalized therapy (2021)
The study evidenced that Majoon-e-Seer Alvi Khan is potentially effective and safe in the treatment of dyslipidemia. However, a multicentre study with a robust study design is required to generalize the results.
Keyphrases
  • clinical trial
  • double blind
  • open label
  • phase ii
  • phase iii
  • placebo controlled
  • randomized controlled trial
  • study protocol